Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)

Clinical trial NCT00324558 · TERMINATED

Trial details

NCT number: NCT00324558
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Small Cell

Start date: 2005-06-01
Primary completion: 2010-02-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.